Catalent Acquires Paragon Bioservices: Expanding Capabilities in Gene Therapy 00:10:00

Share On Facebook Share On Twitter

Mr. James L. Grainer has been the Chairman and Chief Financial Officer of Gene Biotherapeutics Inc. The following section provides information on Gene Biotherapeutics Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Gene Biotherapeutics Inc's management and employees, unlock the full data with our company analytics monitoring tool.

Recent Videos